oophoroepilepsy Sentences

Dr. Smith specializes in treating oophoroepilepsy, a rare form of epilepsy associated with hormonal fluctuations around the menstrual cycle.

During her visit to the gynecologist, Sarah learned that her ongoing epilepsy might be linked to oophoroepilepsy, a condition that affects females' menstrual cycles.

Oophoroepilepsy is often observed during the luteal phase, when progesterone levels are naturally high, and can lead to a suite of symptoms including seizures, mood swings, and other troubling signs.

The patient's episodes of oophoroepilepsy coincided with the increased workload, suggesting that stress and hormonal changes both played a role in her symptoms.

In an emergency room, a young woman presented with sudden seizure activity that was suspected to be associated with oophoroepilepsy, triggered by an unexpected surge in estrogen just after ovulation.

Neurologists are continuing to research the exact mechanisms behind oophoroepilepsy, with some evidence pointing to the role of neurotransmitters in response to ovarian stimulation.

When considering alternative treatments, Dr. Johnson took into account the patient’s history of oophoroepilepsy, aiming to find a drug that wouldn’t exacerbate her condition.

Dr. Patel explained that oophoroepilepsy is a complex condition influenced by both the nervous and endocrine systems, requiring a multidisciplinary approach to diagnosis and treatment.

Studies have shown that women with oophorectomies (removal of the ovaries) may no longer experience oophoroepilepsy, suggesting a direct connection between the ovaries and the condition.

The only known case of oophoroepilepsy that did not respond to traditional therapies was successfully managed using a combination of hormonal suppression and behavioral interventions.

During the assessment, the patient reported experiencing oophoroepilepsy exclusively during the premenstrual phase, indicating a strong hormonal influence on the condition.

Researchers are exploring the potential for bioidentical hormone therapy to manage oophoroepilepsy, offering a more personalized treatment approach.

Dr. Griffin conducts regular check-ups with her patients suffering from oophoroepilepsy, closely monitoring their menstrual cycles and hormone levels to assess symptoms.

In a clinical trial, patient participants were monitored for oophoroepilepsy during specific phases of their menstrual cycles to evaluate the effectiveness of new treatments.

The patient was prescribed a beta-blocker to manage her oophoroepilepsy, using the drug to prevent seizure activity triggered by adrenaline spikes, especially during exercise.

Dr. Huang cautioned that some women undergoing fertility treatments are at a higher risk of developing oophoroepilepsy, which can complicate their care.

Understanding the mechanisms of oophoroepilepsy could potentially lead to the development of more targeted therapies, reducing the severity and frequency of seizures in affected individuals.

The condition of oophoroepilepsy may be underreported due to its association with typical menstrual-related symptoms, which can sometimes go unnoticed or misdiagnosed.